Login / Signup

Persistent impairments 3 years after (neo)adjuvant chemotherapy for breast cancer: results from the MaTox project.

Hans-Jürgen HurtzHans TeschThomas GöhlerUlrich HutzschenreuterJohanna HardeLisa KruggelMartina JänickeNorbert Marschnernull null
Published in: Breast cancer research and treatment (2017)
Our data show that most patients with breast cancer have persistent impairments negatively influencing their daily life even 3 years after treatment. Furthermore, we highlight areas requiring special attention in follow-up care.
Keyphrases
  • quality improvement
  • healthcare
  • palliative care
  • working memory
  • electronic health record
  • physical activity
  • big data
  • pain management
  • machine learning
  • deep learning
  • childhood cancer